The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

Weight loss ... label if weight loss can help with other areas, such as preventing obesity-related health issues. Some people who may not be able to receive Ozempic include: Zepbound works by ...

It is also unsuitable for those living with multiple endocrine neoplasia syndrome type 2 (MEN 2 ... is FDA-approved for weight loss as the brand-name drug Zepbound. It is also FDA-approved ...

While Zepbound is FDA-approved for weight loss, Mounjaro is approved for managing type 2 diabetes. Adults without diabetes lost 15% to 20.9% of their body weight, depending on the dosage.

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...

Weight loss medications like Ozempic and Wegovy have become increasingly popular over the last few years. For people struggling to lose weight through diet and exercise alone, these medications ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...